Global Diabetes Care Device Market
Global Diabetes Care Device Market

Diabetes Care Device Comprehensive Study by Blood Glucose Monitoring Device (Testing Strips, Self-monitoring Blood Glucose Meters, Lancets, Continuous Glucose Monitors), Insulin Delivery Device (Insulin Syringes, Insulin Pens, Insulin Pumps, Insulin Jet Injectors, Others), End User (Hospitals, Ambulatory Surgery Centers, Diagnostic Centers, Academic & Research Institutes, Home Care, Others) Players and Region - Global Market Outlook to 2024

Diabetes Care Device Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

May 2019 Edition 240 Pages 196 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study
The diabetes is caused due to an increase in blood sugar level for a long period. This is due to either pancreas not producing enough insulin or cells of the body not responding to the insulin produced. The main goal of diabetes care devices is to minimize the risk of diabetes and to provide continuous monitoring of sugar level. Increasing obese population and government initiatives for providing diabetes cure treatment are the key drivers for the market. Additionally, rising demand for fast, safe and better diabetes care products have been supplementing the growth of the market. However, lack of awareness of diabetes care devices, rising health awareness across the globe and adverse effects associated with diabetes care devices are directly hampering the overall growth of the market. Moreover, rising international research collaboration for diabetes care products and increasing investment in research and development activities lead to new innovation may create a big opportunity for the market in the coming years.

The market study is being classified and major geographies with country level break-up. and may see market size of USD49.81 Billion by 2024.

Roche Holding AG (Switzerland), Medtronic plc (United States), Johnson & Johnson (United States), Abbott Laboratories (United States), Ascensia Diabetes Care Holdings AG (United States), Becton Dickinson (United States), Dexcom (United States), ARKRAY Healthcare Pvt. Ltd. (India), B. Braun Melsungen (Germany) and Terumo Corporation (Japan) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Ypsomed Holding (Switzerland), Sannuo Biological Sensing Co Ltd (China0, I Sens Inc (South Korea) and Alere Inc. (United States).

The Players having a strong hold in the market are Roche Holding AG, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Ascensia Diabetes. Research Analyst at AMA predicts that United States, European and Asian Players will contribute to the maximum growth of Global Diabetes Care Device market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Diabetes Care Device market by Type, Application and Region.

On the basis of geography, the market of Diabetes Care Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Blood Glucose Monitoring Device, the sub-segment i.e. Testing Strips will boost the Diabetes Care Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Insulin Delivery Device, the sub-segment i.e. Insulin Syringes will boost the Diabetes Care Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Diabetes Care Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Government Initiatives for Providing Diabetes Cure Treatment
  • Rising Demand for Fast, Safe and Better Diabetes Care Products
  • Increasing Obese Population

Market Trend
  • Increasing Population Suffering from Diabetes due to Sedentary Lifestyle

Restraints
  • Lack of Awareness of Diabetes Care Devices
  • Rising Heath Awareness across the Globe

Opportunities
  • Rising International Research Collaboration for Diabetes Care Products
  • Increasing Investment in Research and Development Activities lead to New Innovation

Challenges
  • Adverse effects associated with Diabetes Care Devices


Market Leaders and their expansionary development strategies
In August 2017, pharmaceutical Novo Nordisk had acquired Bristol University spin-out Ziylo in approximately USD 796 million. This acquisition helps the company to develop smart insulin.
In August 2016, Roche Holding AG had launched Accu-Chek Guide blood glucose monitoring system named as Accu-Chek. The new product is design to offers monitoring of glucose on a daily basis along with features such as the spill-resistant SmartPack test strip vial that is used to remove just one strip at a time.


Key Target Audience
Diabetes Care Device Manufacturers, Raw Material Suppliers, Distributors and Suppliers, Government Association, Diabetes Research Organization, Investors and Others

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Blood Glucose Monitoring Device
  • Testing Strips
  • Self-monitoring Blood Glucose Meters
  • Lancets
  • Continuous Glucose Monitors

By Insulin Delivery Device
  • Insulin Syringes
  • Insulin Pens
  • Insulin Pumps
  • Insulin Jet Injectors
  • Others

By End User
  • Hospitals
  • Ambulatory Surgery Centers
  • Diagnostic Centers
  • Academic & Research Institutes
  • Home Care
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Government Initiatives for Providing Diabetes Cure Treatment
      • 3.2.2. Rising Demand for Fast, Safe and Better Diabetes Care Products
      • 3.2.3. Increasing Obese Population
    • 3.3. Market Challenges
      • 3.3.1. Adverse effects associated with Diabetes Care Devices
    • 3.4. Market Trends
      • 3.4.1. Increasing Population Suffering from Diabetes due to Sedentary Lifestyle
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Diabetes Care Device, by Blood Glucose Monitoring Device, Insulin Delivery Device, End User and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Diabetes Care Device (Value)
      • 5.2.1. Global Diabetes Care Device by: Blood Glucose Monitoring Device (Value)
        • 5.2.1.1. Testing Strips
        • 5.2.1.2. Self-monitoring Blood Glucose Meters
        • 5.2.1.3. Lancets
        • 5.2.1.4. Continuous Glucose Monitors
      • 5.2.2. Global Diabetes Care Device by: Insulin Delivery Device (Value)
        • 5.2.2.1. Insulin Syringes
        • 5.2.2.2. Insulin Pens
        • 5.2.2.3. Insulin Pumps
        • 5.2.2.4. Insulin Jet Injectors
        • 5.2.2.5. Others
      • 5.2.3. Global Diabetes Care Device by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Ambulatory Surgery Centers
        • 5.2.3.3. Diagnostic Centers
        • 5.2.3.4. Academic & Research Institutes
        • 5.2.3.5. Home Care
        • 5.2.3.6. Others
      • 5.2.4. Global Diabetes Care Device Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Diabetes Care Device: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Roche Holding AG (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic plc (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Johnson & Johnson (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abbott Laboratories (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Ascensia Diabetes Care Holdings AG (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Becton Dickinson (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Dexcom (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. ARKRAY Healthcare Pvt. Ltd. (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. B. Braun Melsungen (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Terumo Corporation (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Diabetes Care Device Sale, by Blood Glucose Monitoring Device, Insulin Delivery Device, End User and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Diabetes Care Device (Value)
      • 7.2.1. Global Diabetes Care Device by: Blood Glucose Monitoring Device (Value)
        • 7.2.1.1. Testing Strips
        • 7.2.1.2. Self-monitoring Blood Glucose Meters
        • 7.2.1.3. Lancets
        • 7.2.1.4. Continuous Glucose Monitors
      • 7.2.2. Global Diabetes Care Device by: Insulin Delivery Device (Value)
        • 7.2.2.1. Insulin Syringes
        • 7.2.2.2. Insulin Pens
        • 7.2.2.3. Insulin Pumps
        • 7.2.2.4. Insulin Jet Injectors
        • 7.2.2.5. Others
      • 7.2.3. Global Diabetes Care Device by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Ambulatory Surgery Centers
        • 7.2.3.3. Diagnostic Centers
        • 7.2.3.4. Academic & Research Institutes
        • 7.2.3.5. Home Care
        • 7.2.3.6. Others
      • 7.2.4. Global Diabetes Care Device Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Diabetes Care Device: by Blood Glucose Monitoring Device(USD Billion)
  • Table 2. Diabetes Care Device Testing Strips , by Region USD Billion (2013-2018)
  • Table 3. Diabetes Care Device Self-monitoring Blood Glucose Meters , by Region USD Billion (2013-2018)
  • Table 4. Diabetes Care Device Lancets , by Region USD Billion (2013-2018)
  • Table 5. Diabetes Care Device Continuous Glucose Monitors , by Region USD Billion (2013-2018)
  • Table 6. Diabetes Care Device: by Insulin Delivery Device(USD Billion)
  • Table 7. Diabetes Care Device Insulin Syringes , by Region USD Billion (2013-2018)
  • Table 8. Diabetes Care Device Insulin Pens , by Region USD Billion (2013-2018)
  • Table 9. Diabetes Care Device Insulin Pumps , by Region USD Billion (2013-2018)
  • Table 10. Diabetes Care Device Insulin Jet Injectors , by Region USD Billion (2013-2018)
  • Table 11. Diabetes Care Device Others , by Region USD Billion (2013-2018)
  • Table 12. Diabetes Care Device: by End User(USD Billion)
  • Table 13. Diabetes Care Device Hospitals , by Region USD Billion (2013-2018)
  • Table 14. Diabetes Care Device Ambulatory Surgery Centers , by Region USD Billion (2013-2018)
  • Table 15. Diabetes Care Device Diagnostic Centers , by Region USD Billion (2013-2018)
  • Table 16. Diabetes Care Device Academic & Research Institutes , by Region USD Billion (2013-2018)
  • Table 17. Diabetes Care Device Home Care , by Region USD Billion (2013-2018)
  • Table 18. Diabetes Care Device Others , by Region USD Billion (2013-2018)
  • Table 19. South America Diabetes Care Device, by Country USD Billion (2013-2018)
  • Table 20. South America Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 21. South America Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 22. South America Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 23. Brazil Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 24. Brazil Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 25. Brazil Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 26. Argentina Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 27. Argentina Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 28. Argentina Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 29. Rest of South America Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 30. Rest of South America Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 31. Rest of South America Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 32. Asia Pacific Diabetes Care Device, by Country USD Billion (2013-2018)
  • Table 33. Asia Pacific Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 34. Asia Pacific Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 35. Asia Pacific Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 36. China Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 37. China Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 38. China Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 39. Japan Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 40. Japan Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 41. Japan Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 42. India Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 43. India Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 44. India Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 45. South Korea Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 46. South Korea Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 47. South Korea Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 48. Taiwan Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 49. Taiwan Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 50. Taiwan Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 51. Australia Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 52. Australia Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 53. Australia Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 54. Rest of Asia-Pacific Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 55. Rest of Asia-Pacific Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 56. Rest of Asia-Pacific Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 57. Europe Diabetes Care Device, by Country USD Billion (2013-2018)
  • Table 58. Europe Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 59. Europe Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 60. Europe Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 61. Germany Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 62. Germany Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 63. Germany Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 64. France Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 65. France Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 66. France Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 67. Italy Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 68. Italy Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 69. Italy Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 70. United Kingdom Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 71. United Kingdom Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 72. United Kingdom Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 73. Netherlands Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 74. Netherlands Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 75. Netherlands Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 76. Rest of Europe Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 77. Rest of Europe Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 78. Rest of Europe Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 79. MEA Diabetes Care Device, by Country USD Billion (2013-2018)
  • Table 80. MEA Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 81. MEA Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 82. MEA Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 83. Middle East Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 84. Middle East Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 85. Middle East Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 86. Africa Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 87. Africa Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 88. Africa Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 89. North America Diabetes Care Device, by Country USD Billion (2013-2018)
  • Table 90. North America Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 91. North America Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 92. North America Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 93. United States Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 94. United States Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 95. United States Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 96. Canada Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 97. Canada Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 98. Canada Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 99. Mexico Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Table 100. Mexico Diabetes Care Device, by Insulin Delivery Device USD Billion (2013-2018)
  • Table 101. Mexico Diabetes Care Device, by End User USD Billion (2013-2018)
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Diabetes Care Device: by Blood Glucose Monitoring Device(USD Billion)
  • Table 113. Diabetes Care Device Testing Strips , by Region USD Billion (2019-2024)
  • Table 114. Diabetes Care Device Self-monitoring Blood Glucose Meters , by Region USD Billion (2019-2024)
  • Table 115. Diabetes Care Device Lancets , by Region USD Billion (2019-2024)
  • Table 116. Diabetes Care Device Continuous Glucose Monitors , by Region USD Billion (2019-2024)
  • Table 117. Diabetes Care Device: by Insulin Delivery Device(USD Billion)
  • Table 118. Diabetes Care Device Insulin Syringes , by Region USD Billion (2019-2024)
  • Table 119. Diabetes Care Device Insulin Pens , by Region USD Billion (2019-2024)
  • Table 120. Diabetes Care Device Insulin Pumps , by Region USD Billion (2019-2024)
  • Table 121. Diabetes Care Device Insulin Jet Injectors , by Region USD Billion (2019-2024)
  • Table 122. Diabetes Care Device Others , by Region USD Billion (2019-2024)
  • Table 123. Diabetes Care Device: by End User(USD Billion)
  • Table 124. Diabetes Care Device Hospitals , by Region USD Billion (2019-2024)
  • Table 125. Diabetes Care Device Ambulatory Surgery Centers , by Region USD Billion (2019-2024)
  • Table 126. Diabetes Care Device Diagnostic Centers , by Region USD Billion (2019-2024)
  • Table 127. Diabetes Care Device Academic & Research Institutes , by Region USD Billion (2019-2024)
  • Table 128. Diabetes Care Device Home Care , by Region USD Billion (2019-2024)
  • Table 129. Diabetes Care Device Others , by Region USD Billion (2019-2024)
  • Table 130. South America Diabetes Care Device, by Country USD Billion (2019-2024)
  • Table 131. South America Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 132. South America Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 133. South America Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 134. Brazil Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 135. Brazil Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 136. Brazil Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 137. Argentina Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 138. Argentina Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 139. Argentina Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 140. Rest of South America Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 141. Rest of South America Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 142. Rest of South America Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 143. Asia Pacific Diabetes Care Device, by Country USD Billion (2019-2024)
  • Table 144. Asia Pacific Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 145. Asia Pacific Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 146. Asia Pacific Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 147. China Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 148. China Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 149. China Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 150. Japan Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 151. Japan Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 152. Japan Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 153. India Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 154. India Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 155. India Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 156. South Korea Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 157. South Korea Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 158. South Korea Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 159. Taiwan Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 160. Taiwan Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 161. Taiwan Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 162. Australia Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 163. Australia Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 164. Australia Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 165. Rest of Asia-Pacific Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 166. Rest of Asia-Pacific Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 167. Rest of Asia-Pacific Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 168. Europe Diabetes Care Device, by Country USD Billion (2019-2024)
  • Table 169. Europe Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 170. Europe Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 171. Europe Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 172. Germany Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 173. Germany Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 174. Germany Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 175. France Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 176. France Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 177. France Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 178. Italy Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 179. Italy Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 180. Italy Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 181. United Kingdom Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 182. United Kingdom Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 183. United Kingdom Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 184. Netherlands Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 185. Netherlands Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 186. Netherlands Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 187. Rest of Europe Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 188. Rest of Europe Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 189. Rest of Europe Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 190. MEA Diabetes Care Device, by Country USD Billion (2019-2024)
  • Table 191. MEA Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 192. MEA Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 193. MEA Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 194. Middle East Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 195. Middle East Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 196. Middle East Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 197. Africa Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 198. Africa Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 199. Africa Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 200. North America Diabetes Care Device, by Country USD Billion (2019-2024)
  • Table 201. North America Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 202. North America Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 203. North America Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 204. United States Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 205. United States Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 206. United States Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 207. Canada Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 208. Canada Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 209. Canada Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 210. Mexico Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Table 211. Mexico Diabetes Care Device, by Insulin Delivery Device USD Billion (2019-2024)
  • Table 212. Mexico Diabetes Care Device, by End User USD Billion (2019-2024)
  • Table 213. Research Programs/Design for This Report
  • Table 214. Key Data Information from Secondary Sources
  • Table 215. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Diabetes Care Device: by Blood Glucose Monitoring Device USD Billion (2013-2018)
  • Figure 5. Global Diabetes Care Device: by Insulin Delivery Device USD Billion (2013-2018)
  • Figure 6. Global Diabetes Care Device: by End User USD Billion (2013-2018)
  • Figure 7. South America Diabetes Care Device Share (%), by Country
  • Figure 8. Asia Pacific Diabetes Care Device Share (%), by Country
  • Figure 9. Europe Diabetes Care Device Share (%), by Country
  • Figure 10. MEA Diabetes Care Device Share (%), by Country
  • Figure 11. North America Diabetes Care Device Share (%), by Country
  • Figure 12. Global Diabetes Care Device share by Players 2018 (%)
  • Figure 13. Global Diabetes Care Device share by Players (Top 3) 2018(%)
  • Figure 14. Global Diabetes Care Device share by Players (Top 5) 2018(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Roche Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 17. Roche Holding AG (Switzerland) Revenue: by Geography 2018
  • Figure 18. Medtronic plc (United States) Revenue, Net Income and Gross profit
  • Figure 19. Medtronic plc (United States) Revenue: by Geography 2018
  • Figure 20. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 21. Johnson & Johnson (United States) Revenue: by Geography 2018
  • Figure 22. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 23. Abbott Laboratories (United States) Revenue: by Geography 2018
  • Figure 24. Ascensia Diabetes Care Holdings AG (United States) Revenue, Net Income and Gross profit
  • Figure 25. Ascensia Diabetes Care Holdings AG (United States) Revenue: by Geography 2018
  • Figure 26. Becton Dickinson (United States) Revenue, Net Income and Gross profit
  • Figure 27. Becton Dickinson (United States) Revenue: by Geography 2018
  • Figure 28. Dexcom (United States) Revenue, Net Income and Gross profit
  • Figure 29. Dexcom (United States) Revenue: by Geography 2018
  • Figure 30. ARKRAY Healthcare Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 31. ARKRAY Healthcare Pvt. Ltd. (India) Revenue: by Geography 2018
  • Figure 32. B. Braun Melsungen (Germany) Revenue, Net Income and Gross profit
  • Figure 33. B. Braun Melsungen (Germany) Revenue: by Geography 2018
  • Figure 34. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 35. Terumo Corporation (Japan) Revenue: by Geography 2018
  • Figure 36. Global Diabetes Care Device: by Blood Glucose Monitoring Device USD Billion (2019-2024)
  • Figure 37. Global Diabetes Care Device: by Insulin Delivery Device USD Billion (2019-2024)
  • Figure 38. Global Diabetes Care Device: by End User USD Billion (2019-2024)
  • Figure 39. South America Diabetes Care Device Share (%), by Country
  • Figure 40. Asia Pacific Diabetes Care Device Share (%), by Country
  • Figure 41. Europe Diabetes Care Device Share (%), by Country
  • Figure 42. MEA Diabetes Care Device Share (%), by Country
  • Figure 43. North America Diabetes Care Device Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Roche Holding AG (Switzerland)
  • Medtronic plc (United States)
  • Johnson & Johnson (United States)
  • Abbott Laboratories (United States)
  • Ascensia Diabetes Care Holdings AG (United States)
  • Becton Dickinson (United States)
  • Dexcom (United States)
  • ARKRAY Healthcare Pvt. Ltd. (India)
  • B. Braun Melsungen (Germany)
  • Terumo Corporation (Japan)
Additional players considered in the study are as follows:
Ypsomed Holding (Switzerland) , Sannuo Biological Sensing Co Ltd (China0 , I Sens Inc (South Korea) , Alere Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation